Filing Details

Accession Number:
0001127602-16-055579
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-06-15 16:03:29
Reporting Period:
2016-06-13
Filing Date:
2016-06-15
Accepted Time:
2016-06-15 16:03:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
920148 Laboratory Corp Of America Holdings LH Services-Medical Laboratories (8071) 133757370
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1275654 P David King 531 South Spring Street
Burlington NC 27215
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-06-13 123,839 $70.15 271,210 No 4 M Direct
Common Stock Disposition 2016-06-13 73,455 $127.76 197,755 No 4 S Direct
Common Stock Disposition 2016-06-13 45,884 $128.79 151,871 No 4 S Direct
Common Stock Disposition 2016-06-13 4,500 $129.47 147,371 No 4 S Direct
Common Stock Acquisiton 2016-06-13 72,561 $70.15 219,932 No 4 M Direct
Common Stock Disposition 2016-06-13 72,561 $127.65 147,371 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-qualified Stock Options Disposition 2016-06-13 123,839 $0.00 123,839 $70.15
Common Stock Non-qualified Stock Options Disposition 2016-06-13 72,561 $0.00 72,561 $70.15
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
72,561 2011-02-09 2020-02-09 No 4 M Direct
0 2011-02-09 2020-02-09 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 24,383 Indirect By grantor retained annuity trust
Common Stock 19,046 Indirect By grantor retained annuity trust
Footnotes
  1. Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.
  2. The price of $127.7622 per share represents a weighted average of sales prices ranging from $127.36 to $128.35 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
  3. The price of $128.7945 per share represents a weighted average of sales prices ranging from $128.36 to $129.35 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
  4. The price of $129.4724 per share represents a weighted average of sales prices ranging from $129.36 to $129.72 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
  5. The price of $127.6463 per share represents a weighted average of sales prices ranging from $127.43 to $128.14 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
  6. Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2008 Stock Incentive Plan.
  7. The option vested in three equal annual installments beginning on 02/09/2010 and is now fully exercisable.